08:00 , Dec 8, 2014 |  BC Week In Review  |  Financial News

Pieris completes venture financing

Pieris AG , Freising-Weihenstephan, Germany   Business: Cancer, Inflammation, Ophthalmic   Date completed: 2014-11-26   Type: Venture financing   Raised: €6.6 million ($8.2 million)   Investors: Ally Bridge Group; OrbiMed Advisors; Global Life Science Ventures;...
07:00 , May 8, 2006 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe U.S. investment in Europe European venture rounds in excess of $30 million in the past year. Selected firms that do not list a major office in Europe are in boldface. Temasek...
07:00 , Aug 8, 2005 |  BioCentury  |  Product Development

Corporate Profile

IntegraGen S.A. Evry, France Technology: GenomeHIP (Genome Hybrid Identity Profiling) Disease focus: Endocrine, neurology Clinical status: Market Founded: 2000 by Joerg Hager, Philippe Gesnouin, Peter Brooks, Anne Philippi, Nathalie Vionnet University collaborators: Hopital Hotel-Dieu; Hopital...
00:44 , May 24, 2005 |  BC Extra  |  Financial News

elbion raises EUR 10 million

elbion (Radebeul, Germany) raised EUR 10 million ($12.6 million) in the second closing of its series A round, bringing the total to EUR 35 million ($44 million). New investors TVM Techno Venture Management; Temasek Holdings;...
07:00 , May 23, 2005 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe Company Name Country Raised Investors Arpida Switzerland $67.4 Swissfirst; Temasek Capital; Carnegie Asset Management; CDIB BioScience Ventures; CITA; MVI Medical Venture Investments; Schroder Ventures Life Sciences; Alta Berkeley Associates; Aventic; BioMedinvest;...
08:00 , Jan 10, 2005 |  BioCentury  |  Finance

Ebb & Flow

Last week saw two series D rounds go in opposite directions. Cancer play Nereus opted for a two-part financing, and maintains that having milestone-contingent money is important for discipline. On the flip side, drug delivery...
08:00 , Jan 10, 2005 |  BioCentury  |  Emerging Company Profile

Corporate Profile

elbion AG Radebeul, Germany Technology: Small molecule drug discovery and medicinal chemistry Disease focus: CNS, inflammatory and respiratory diseases Clinical status: Phase II Founded: 2002 by Bernd Kastler, Thomas Kronbach, Thorsten Hage, Norbert Hoefgen and...
08:00 , Nov 4, 2002 |  BioCentury  |  Finance

Ebb & Flow

Equities - including biotech - put in a good showing in the first month of the fourth quarter, providing an especially upbeat sign given that October is typically the worst month of the year for...
08:00 , Oct 31, 2002 |  BC Extra  |  Financial News

Pieris raises EUR12 million

Pieris Proteolab (Freising, Germany) raised EUR12 million ($11.7 million) in a series A round led by Global Life Science Ventures; and Gilde Investment Management. Other investors included BayTech Venture Capital; ABN AMRO; BioM; and TransConnect....